SEC Form 4 · accession 0001144204-17-018721
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ian Johnson
Officer — President and CEO · Director
Period of report
Apr 3, 2017
Accepted (ET)
Apr 4, 2017 · 9:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 3, 2017 | P | 250,000 | $0.40 | A | 1,194,535 | D |
Table II — derivative securities
No Table II lines on this filing.